tiprankstipranks
Trending News
More News >
Dalrada Financial Corporation (DFCO)
OTHER OTC:DFCO
US Market
Advertisement

Dalrada Financial (DFCO) AI Stock Analysis

Compare
21 Followers

Top Page

DFCO

Dalrada Financial

(OTC:DFCO)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
Dalrada Financial's overall performance is hindered by significant financial challenges, including negative earnings and high leverage. While there are some positive short-term technical indicators, the overbought conditions suggest potential volatility. The valuation remains unattractive, primarily due to negative profitability metrics.

Dalrada Financial (DFCO) vs. SPDR S&P 500 ETF (SPY)

Dalrada Financial Business Overview & Revenue Model

Company DescriptionDalrada Financial Corporation and its subsidiaries provide clean energy, healthcare, technology, and precision engineering solutions. It operates through Engineering, Health, Information Technology, Education, and Corporate. The company engages in the manufacture and distribution of medical disposables, hospital equipment and furniture, medical devices, and laboratory and dental products, as well as sanitizing, disinfectant, and PPE products and services; and provision of mechanical contract services. It also provides advanced solutions for the harvesting and recycling of energy to maximize the capture and reuse of thermal energy for integrated heating and cooling applications, such as industrial, commercial, and residential sectors. In addition, the company offers software and technology solutions that specializes in test engineering, accessibility engineering, product engineering and application modernization; cleaning solutions using electrostatic machines to spray and deodorize residential spaces, healthcare facilities, hospitality, transportation, manufacturing, automotive, schools/education systems, and other facilities. Further, it provides trained nursing and medical assistants for hospitals and home health facilities; and regenerative therapy as a potential solution for the prevention, detection, and treatment of cellular breakdown associated with aging and various other conditions, as well as explores various products and services within the immunization and personal protective equipment industry. The company has operations in Malaysia, India, the United Kingdom, and the United States. Dalrada Financial Corporation was founded in 1982 and is based in Escondido, California.
How the Company Makes MoneyDalrada Financial Corporation generates revenue through a diversified model that includes sales of healthcare products and services, clean energy solutions, and technology systems. The healthcare segment provides diagnostic testing and health-related services, contributing a significant portion of the company's earnings. The clean energy division focuses on selling eco-friendly energy solutions and systems, which is an expanding area due to increasing demand for sustainable practices. Additionally, Dalrada's technology platforms offer innovative solutions that facilitate business operations and efficiency for clients across various industries. Strategic partnerships and a focus on emerging markets further bolster Dalrada's revenue streams and growth potential.

Dalrada Financial Financial Statement Overview

Summary
Dalrada Financial faces significant financial challenges, characterized by declining revenues, persistent losses, high debt levels, and poor cash flow generation. The negative profitability and cash flow metrics indicate operational inefficiencies and cost management issues, while the high leverage poses a risk to financial stability.
Income Statement
40
Negative
Dalrada Financial's revenue has experienced significant volatility, with a notable decrease in the most recent year compared to the previous year. The company has consistently reported negative EBIT and net income, resulting in poor profit margins. The gross profit margin decreased from 30.5% in 2023 to 23.1% in 2024, and the net profit margin worsened from -68.2% to -91.4% during the same period. These metrics indicate challenges in managing costs and achieving profitability.
Balance Sheet
30
Negative
The balance sheet reveals a high debt-to-equity ratio due to significant debt levels and relatively low or negative equity in recent years. The debt-to-equity ratio was approximately 1.30 in 2024. Further, the equity ratio is low at 30.9%, reflecting a reliance on debt financing. The company's negative equity in prior years raises concerns about financial stability and leverage risks.
Cash Flow
35
Negative
Dalrada Financial has struggled with negative operating and free cash flows, indicating difficulties in generating cash from operations. The free cash flow growth rate was negative, with free cash flow worsening from -$5.77 million in 2023 to -$8.36 million in 2024. The operating cash flow to net income ratio is unfavorable, highlighting challenges in converting earnings into cash.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue17.50M20.30M25.18M29.74M19.27M3.41M
Gross Profit1.53M5.30M5.81M9.06M10.51M934.72K
EBITDA-23.90M-20.46M-21.15M-17.37M-9.88M783.99K
Net Income-27.62M-24.65M-23.01M-20.29M-14.10M91.43K
Balance Sheet
Total Assets21.75M18.36M27.60M25.17M22.42M4.70M
Cash, Cash Equivalents and Short-Term Investments98.84K172.79K501.93K812.81K772.06K110.28K
Total Debt16.55M14.51M11.12M8.43M24.21M13.97M
Total Liabilities33.73M25.05M19.17M20.92M37.38M18.11M
Stockholders Equity-11.83M-6.75M8.53M4.11M-15.43M-13.37M
Cash Flow
Free Cash Flow-9.25M-18.35M-8.36M-5.78M-11.23M-5.94M
Operating Cash Flow-9.13M-17.97M-7.93M-4.61M-10.35M-5.58M
Investing Cash Flow-759.67K-697.02K-552.66K-1.06M-574.04K-385.83K
Financing Cash Flow8.69M18.82M8.12M5.72M11.67M5.96M

Dalrada Financial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.04
Price Trends
50DMA
0.06
Negative
100DMA
0.04
Positive
200DMA
0.04
Positive
Market Momentum
MACD
<0.01
Negative
RSI
53.38
Neutral
STOCH
111.11
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DFCO, the sentiment is Positive. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.06, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.38 is Neutral, neither overbought nor oversold. The STOCH value of 111.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DFCO.

Dalrada Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$4.55M36.75%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
51
Neutral
$151.59M-61.44%9.88%-10.83%-1669.11%
46
Neutral
$6.85M-269.70%12.03%24.23%
43
Neutral
$30.78M0.71112.00%-5.47%-113.35%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DFCO
Dalrada Financial
0.04
-0.06
-60.00%
RGP
Resources Connection
4.25
-3.67
-46.34%
GRNQ
Greenpro Capital
1.36
0.47
52.81%
AERT
Aeries Technology
0.64
-1.42
-68.93%
VCIG
VCI Global Limited
3.75
-2,524.65
-99.85%
ROMA
Roma Green Finance Limited
2.79
1.83
190.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 15, 2025